The importance of the recognition of benign ethnic neutropenia in black patients during treatment with clozapine: Case reports and database study

Journal of Psychopharmacology

Volumn 25, Issue 6, 2011, Pages 842-845

  Whiskey, Eromona ^a   Olofinjana, Olubanke ^a   Taylor, David ^a  

^a Lambeth Hospital   (United Kingdom)

Author keywords

black; Clozapine; neutropenia

Indexed keywords

AMISULPRIDE; ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; HALOPERIDOL; LITHIUM; NEUROLEPTIC AGENT; PIPOTIAZINE; QUETIAPINE;

ADULT; ARTICLE; BENIGN ETHNIC NEUTROPENIA; DATA BASE; DRUG DOSE INCREASE; DRUG WITHDRAWAL; ETHNIC DIFFERENCE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGRO; NEUTROPENIA; NEUTROPHIL COUNT; PATIENT MONITORING; PRIORITY JOURNAL; REGISTER; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; TARDIVE DYSKINESIA; TREATMENT OUTCOME; UNITED KINGDOM;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; CLOZAPINE; FEMALE; HUMANS; LONDON; MALE; MIDDLE AGED; NEUTROPENIA; REGISTRIES;

EID: 79960492833     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881110364267     Document Type: Article

References (15)

1. Ahokas A, Elonen E. Circadian rhythm of white blood cells during clozapine treatment. Psychopharmacology. 1999 ; 144: 301-302 (Pubitemid 29307284)
2. Bain BJ. Ethnic and sex differences in the total and differential white cell count and platelet count. J Clin Pathol. 1996 ; 49: 664-666 (Pubitemid 26264395)
3. Esposito D, Aouille J, Rouillon F, Limosin F. Morning pseudo-neutropenia during clozapine treatment. World J Biol Psychiatry. 2003 ; 4: 192-194
4. Gaebel W, Weinmann S, Sartorius N, Rutz W, McIntyre JS. Schizophrenia practice guidelines: international survey and comparison. Br J Psychiatry. 2005 ; 187: 248-255 (Pubitemid 41306106)
5. Haddy TB, Rana SR, Castro O. Benign ethnic neutropenia: what is a normal absolute neutrophil count?. J Lab Clin Med. 1999 ; 133: 15-22 (Pubitemid 29032412)
6. Hagg S, Spigset O, Soderstrom TG. Association of venous thromboembolism and clozapine. Lancet. 2000 ; 355: 1155-1156 (Pubitemid 30172939)
7. Hummer M, Kurz M, Barnas C, Fleischhacker W. Clozapine-induced transient white blood count disorders. J Clin Psychiatry. 1994 ; 55: 429-432
8. Kelly DL, Kreyenbuhl J, Dixon L, Love RC, Medoff D, Conley RR. Clozapine underutilization and discontinuation in African Americans due to leucopenia. Schizophr Bull. 2007 ; 33: 1221-1224 (Pubitemid 47347911)
9. Killian JG, Kerr K, Lawrence C, Calermajer DS. Myocarditis and cardiomyopathy associated with clozapine. Lancet. 1999 ; 354: 1841-1845
10. McEvoy JP, Lieberman JA, Stroup TS, et al. Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment. Am J Psychiatry. 2006 ; 163: 600-610 (Pubitemid 44464569)
11. Munro J, O'Sullivan D, Andrews C, Arana A, Mortimer A, Kerwin R. Active monitoring of 12,760 clozapine recipients in the UK and Ireland. Beyond pharmacovigilance. Br J Psychiatry. 1999 ; 175: 576-580
12. National Institute for Health and Clinical Excellence (2009) Core interventions in the treatment and management of schizophrenia in primary and secondary care (update.) National Clinical Practice Guideline number 82. London: National Institute for Health and Clinical Excellence.
13. Rajagopal S. Clozapine, agranulocytosis, and benign ethnic neutropenia. Postgrad Med J. 2005 ; 81: 545-546 (Pubitemid 41297905)
14. Taylor DM, Douglas-Hall P, Olofinjana B, Whiskey E, Thomas A. Reasons for discontinuing clozapine: matched, case-control comparison with risperidone long-acting injection. Br J Psychiatry. 2009 ; 194: 165-167
15. Whiskey E, Taylor DM. Restarting clozapine after neutropenia: evaluating the possibilities and practicalities. CNS Drugs. 2007 ; 21: 25-35 (Pubitemid 46072348)